New Delhi, May 20: The Delhi High Court has issued a notice to the Central Government regarding the illegal export of life-saving anti-cancer drugs manufactured solely for domestic use in India. The court is seeking a response in light of allegations that certain companies are exploiting verification system loopholes to export these drugs abroad, mixing them with legitimate export shipments.
The petitioner informed the court that these drugs, intended for Indian patients, particularly cancer sufferers, are being sent overseas by some companies and exporters. This practice is causing a shortage of essential medications in the country, adversely affecting patients battling serious illnesses.
The court has directed the Central Government, the Central Drugs Standard Control Organization (CDSCO), the Directorate General of Foreign Trade (DGFT), the Central Board of Indirect Taxes and Customs (CBIC), the Directorate of Revenue Intelligence (DRI), and the Goods and Services Tax Intelligence Directorate (DGGI) to respond within four weeks.
The petition claims that the illegal trade not only jeopardizes patient lives but also negatively impacts the country’s drug distribution system and healthcare services. During the hearing, the High Court pressed the Health Ministry and relevant departments on the concrete measures being taken to curb the trend of exporting domestically needed medications under the guise of exports.
My name is Ganpat Singh Choughan. I am an experienced content writer with 7 years of expertise in the field. Currently, I contribute to Daily Kiran, creating engaging and informative content across a variety of categories including technology, health, travel, education, and automobiles. My goal is to deliver accurate, insightful, and captivating information through my words to help readers stay informed and empowered.
Leave a Comment